Dysregulation of IL-6 and IL-11 signaling contributes to several diseases, such as inflammatory bowel disease, osteoporosis, rheumatoid arthritis, and various types of cancer [11, 12]. This evidence concerns the gene IL11 and rheumatoid arthritis.